Insulin is a hormone for Type 1 diabetes treatment, the rationale for AD treatment is that brain areas affected in AD patients show decrease in the concentration of insulin and increase in the number of insulin receptors [70]. This evidence concerns the gene INS and type 1 diabetes mellitus.